Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Brr2-IN-3 (Brr2 Inhibitor C9) is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 76.00 | |
5 mg | In stock | $ 163.00 | |
10 mg | In stock | $ 289.00 | |
25 mg | In stock | $ 538.00 | |
50 mg | In stock | $ 778.00 | |
100 mg | In stock | $ 1,090.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 197.00 |
Description | Brr2-IN-3 (Brr2 Inhibitor C9) is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders). |
Targets&IC50 | BRR2:1.3 μM (IC50) |
Synonyms | Brr2 Inhibitor 9, Brr2 Inhibitor C9 |
Molecular Weight | 444.51 |
Formula | C24H20N4O3S |
CAS No. | 2104030-82-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (61.87 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Brr2-IN-3 2104030-82-0 Others Brr2 Inhibitor 9 Inhibitor selective dose-dependent Brr2IN3 inhibit helicase Brr-2-IN-3 targeting potent Brr2 Inhibitor C9 allosteric Brr2 IN 3 inhibitor